MTSS2: A Mitochondrial Protein with Potential as A Drug Target Or Biomarker
MTSS2: A Mitochondrial Protein with Potential as A Drug Target Or Biomarker
MTSS2 (Mitochondrial Targeted Small Subunits 2) is a protein that is expressed in the mitochondria, which are organelles responsible for generating energy in the cell. It is a key regulator of mitochondrial function and has been identified as a potential drug target or biomarker for various diseases.
The mitochondria are organelles that are found in the cells of all eukaryotes, including humans. They are responsible for generating energy through a process called cellular respiration. This process involves the breakdown of glucose molecules into carbon dioxide and water, releasing a large amount of energy in the form of ATP. Mitochondria also play a key role in the regulation of cell growth, apoptosis, and inflammation.
MTSS2 is a protein that is expressed in the mitochondria and is involved in the regulation of various cellular processes. It is a key regulator of mitochondrial function and has been identified as a potential drug target or biomarker for various diseases.
One of the key functions of MTSS2 is its role in regulating mitochondrial protein synthesis. MTSS2 is a key regulator of the translation of mRNAs into mitochondrial proteins, which are involved in various cellular processes, including energy metabolism, cell signaling, and inflammation. By regulating the translation of mRNAs into proteins, MTSS2 helps to ensure that the cell has a sufficient supply of proteins to perform its necessary functions.
MTSS2 is also involved in the regulation of mitochondrial dynamics. Mitochondria are dynamic organelles that are constantly moving and changing in order to optimize their function. MTSS2 helps to regulate the movement of mitochondria into the cytoplasm, where they can access their clients and carry out their tasks more effectively.
MTSS2 is also involved in the regulation of cellular processes that are critical for the survival of the cell. For example, MTSS2 has been shown to be involved in the regulation of cellular apoptosis, which is the process by which cells decide when to die and are Programmed death. MTSS2 has been shown to play a key role in the regulation of apoptosis by promoting the production of pro-apoptotic proteins.
MTSS2 is also involved in the regulation of inflammation. MTSS2 has been shown to be involved in the regulation of inflammation by promoting the production of pro-inflammatory proteins. This helps to protect the cell from infection and inflammation, but also contributes to the development of diseases such as rheumatoid arthritis and inflammatory bowel disease.
MTSS2 is also a potential drug target. MTSS2 has been shown to be involved in a variety of cellular processes that are important for the survival of the cell. As a result, MTSS2 has been identified as a potential drug target for various diseases. For example , studies have shown that inhibiting MTSS2 activity can protect the cell from the effects of certain drugs, such as chemotherapy drugs.
In addition, MTSS2 may also be a biomarker for certain diseases. MTSS2 is expressed in a variety of tissues and cells, including the brain, heart, and skeletal muscles. As a result, MTSS2 has been used as a biomarker for a variety of diseases. , including cancer, neurodegenerative diseases, and cardiovascular disease.
In conclusion, MTSS2 is a protein that is expressed in the mitochondria and is involved in the regulation of various cellular processes. It is a key regulator of mitochondrial function and has been identified as a potential drug target or biomarker for various diseases. Further research is needed to fully understand the role of MTSS2 in cellular processes and its potential as a drug target or biomarker.
Protein Name: MTSS I-BAR Domain Containing 2
Functions: Involved in plasma membrane dynamics. Potentiated PDGF-mediated formation of membrane ruffles and lamellipodia in fibroblasts, acting via RAC1 activation (PubMed:14752106). May function in actin bundling (PubMed:14752106)
The "MTSS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTSS2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MTTP | MTURN | MTUS1 | MTUS1-DT | MTUS2 | MTUS2-AS1 | MTVR2 | MTX1 | MTX2 | MTX3 | mu-Calpain (calpain 1) | MUC1 | MUC12 | MUC13 | MUC15 | MUC16 | MUC17 | MUC19 | MUC2 | MUC20 | MUC20P1 | MUC21 | MUC22 | MUC3A | MUC3B | MUC4 | MUC5AC | MUC5B | MUC6 | MUC7 | MUC8 | Mucin | MUCL1 | MUCL3 | MUL1 | Multisubunit histone acetyltransferase complex | MUPP | MUS81 | Muscarinic Acetylcholine Receptor (mAChR) | MUSK | MUSTN1 | MUTYH | MVB12A | MVB12B | MVD | MVK | MVP | MX1 | MX2 | MXD1 | MXD3 | MXD4 | MXI1 | MXRA5 | MXRA5Y | MXRA7 | MXRA8 | MYADM | MYADML | MYADML2 | MYB | MYBBP1A | MYBL1 | MYBL2 | MYBPC1 | MYBPC2 | MYBPC3 | MYBPH | MYBPHL | MYC | MYCBP | MYCBP2 | MYCBP2-AS1 | MYCBPAP | MYCL | MYCL-AS1 | MYCLP1 | MYCN | MYCNOS | MYCNUT | MYCT1 | MYD88 | MYDGF | MYEF2 | Myelin Protein | MYEOV | MYF5 | MYF6 | MYG1 | MYH1 | MYH10 | MYH11 | MYH13 | MYH14 | MYH15 | MYH16 | MYH2 | MYH3 | MYH4 | MYH6
